More witness

Some weeks ago, a Commentary titled "Time to Bear Witness" called for the biotech industry to build a "full head" of steam into the congressional engine for FDA reform. We called for a "blizzard of documentation" about the failings of the regulatory environment, and said lawmakers "should get an earful" about the price the public pays for